TSCAN THERAPEUTICS, INC. (TCRX)
Cellares and TScan Therapeutics Announce Agreement to Evaluate Automated Manufacturing of TSC-101 for Patients with Hematologic Malignancies
Cellares and TScan Therapeutics Announce Agreement to Evaluate Automated Manufacturing of TSC-101 for Patients with Hematologic Malignancies
📈 **POSITIVE** • High confidence analysis (86%) • Strong positive business development • Significant competitive advantage **Sentiment:** Positive (95%) **Content type:** Business